Home   News   National   Article

New model of Covid-19 spike protein ‘could help vaccine development’


By PA News

Easier access to your trusted, local news. Subscribe to a digital package and support local news publishing.



Click here to sign up to our free newsletters!
Patches of intense purple at the surface of the spike protein indicate potential target sites for antibodies that are not protected by the glycans, shown in green (Mateusz Sikora/PA)

New vulnerable sites on the surface of the Covid-19 spike protein have been identified by scientists who say their work could help in the development of vaccines.

Coronavirus is studded with spike proteins that it uses to enter human cells.

Covid-19 vaccines work by teaching the immune system to make antibodies to the spike protein.

Researchers in Germany have developed a detailed model of the spike protein to identify potential target sites on its surface for the antibodies.

Our approach can support the design of vaccines and therapeutic antibodies, especially when established methods struggle
Researcher Mateusz Sikora

They said previous models have not shown the flexibility of the spike protein or the movements of the protective glycans – which they describe as chains of sugar molecules – that coat it.

The team, from the Max Planck Institute of Biophysics in Frankfurt, said the glycans help the virus evade a person’s immune system by moving back and forth in a motion they likened to car windscreen wipers.

The researchers said their simulations, published in the PLOS Computational Biology journal, allowed them to identify spots on the surface of the spike protein that are least protected by the glycan “shields”.

While some of the sites detected were known from previous research, the team said they managed to identify some new ones.

Researcher Mateusz Sikora said: “We are in a phase of the pandemic driven by the emergence of new variants of SARS-CoV-2 (the coronavirus that causes Covid-19) with mutations concentrated in particular in the spike protein.

“Our approach can support the design of vaccines and therapeutic antibodies, especially when established methods struggle.”

Do you want to respond to this article? If so, click here to submit your thoughts and they may be published in print.

Keep up-to-date with important news from your community, and access exclusive, subscriber only content online. Read a copy of your favourite newspaper on any device via the HNM App.

Learn more


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More